Pradaxa Related Clinical Trials
A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation [Completed]
Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers [Completed]
Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma [Not yet recruiting]
Investigation Drug-drug Interaction Between Dabigatran and Clarithromycin [Completed]
Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects [Completed]
Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects [Completed]
Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF [Recruiting]
Management of Myocardial Injury After Noncardiac Surgery Trial [Recruiting]
Bioavailability of BIBR 953 ZW in Healthy Subjects [Completed]
Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism [Recruiting]
Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects [Completed]
Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects [Completed]
An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate in Hemodialysis Patients [Completed]
Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively [Recruiting]
Pharmacokinetics of Dabigatran Etexilate (PradaxaŽ) During Haemodialysis [Completed]
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery [Completed]
Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers [Completed]
Effect of Inhibitors of the Proton Pump on Intestinal Transporters and Their Impact on the Pharmacokinetics of Dabigatran - Mechanistic and Clinical Approach -BIPP Study [Active, not recruiting]
Effects of LMWH Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease [Recruiting]
Drug Interaction Study Between Bosutinib And Dabigatran [Completed]
Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran [Recruiting]
Bioequivalence of Two Different Capsule Types of Dabigatran [Completed]
Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation [Recruiting]
Dabigatran Etexilate in Patients With Mechanical Heart Valves [Terminated]
Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects [Completed]
Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy [Completed]
Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor [Completed]
Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran [Completed]
A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin [Completed]
Bioavailability of BIBR 953 ZW Under Influence of Food in Healthy Subjects [Completed]
Bioavailability of BIBR 1048 MS Tablets in Healthy Subjects With or Without Food [Completed]
Relative Bioavailability of Dabigatran and Diclofenac After Dabigatran Etexilate and Diclofenac Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers [Completed]
Dabigatran Following Transient Ischemic Attack and Minor Stroke [Recruiting]
Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers [Completed]
Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke [Completed]
Relative Bioavailability of Single Doses of Dabigatran Etexilate When Administered Alone or in Combination With a Single Dose of Ketoconazole or in Combination With q.d. Ketoconazole at Steady State in Healthy Male and Female Volunteers [Completed]
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. [Completed]
Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy Subjects [Completed]
Bioequivalence of Two Different Polymorphs of Dabigatran Etexilate in Healthy Male and Female Volunteers [Completed]
Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males [Completed]
Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age [Recruiting]
Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects [Completed]
Bioequivalence of Two Different Generations of Drug Product of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers [Completed]
Bioavailability of BIBR 953 ZW After BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as Hydroxypropyl Methylcellulose (HPMC) Polymorph II Capsule Relative to HPMC Polymorph I Capsule in Healthy Subjects. [Completed]
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate [Completed]
Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin [Completed]
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) [Recruiting]
Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention [Completed]
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function [Completed]
Cognitive Impairment Related to Atrial Fibrillation Prevention Trial [Recruiting]
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment [Completed]
Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function [Recruiting]
Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MS [Completed]
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE [Completed]
Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female Volunteers [Completed]
Reversal of Dabigatran With Prothrombin Complex Concentrate [Recruiting]
Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) [Recruiting]
Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease. [Completed]
RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome [Completed]
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 [Terminated]
Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa [Completed]
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age [Recruiting]
Safety Study of Dabigatran in CADASIL [Recruiting]
Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy [Withdrawn]
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement [Completed]
Bioavailability of Different Applications of Dabigatran in Healthy Volunteers [Completed]
Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin [Completed]
Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation [Active, not recruiting]
Dabigatran Adherence Pilot Intervention for Patients With Atrial Fibrillation [Completed]
Pharmacogenomic Study on PKD/PKC of Dabigatran Etexilate and Rivaroxaban [Completed]
Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery [Completed]
DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation [Recruiting]
Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects. [Completed]
Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects [Completed]
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children [Recruiting]
Effect of Dabigatran on Coagulation parameters-an ex Vivo Study [Completed]
Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran Etexilate [Completed]
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery [Completed]
Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects [Completed]
Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects [Completed]
Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban. [Recruiting]
RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery [Completed]
Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery [Terminated]
Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA [Completed]
Dabigatran in an Interaction Probe Drug Cocktail [Recruiting]
Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers [Completed]
Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery [Not yet recruiting]
Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers [Completed]
Reversal of the Antithrombotic Action of New Oral Anticoagulants [Recruiting]
Early Versus Late DC-cardioversion of Persistent Atrial Fibrillation. Effect on Atrial Remodeling,Inflammatory and Neurohumoral Markers and Recurrence of Atrial Fibrillation [Completed]
BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery [Completed]
Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk [Not yet recruiting]
Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty [Completed]
|
